Novel therapeutic agents for HbF induction: a new era for treatment of β thalassemia?

<p>Fetal globin is endogenous, normally integrated in hematopoietic stem cells in all humans, and available for reactivation. Inducing expression of fetal globin (g-globin) gene expression to 60-70% of a globin synthesis produces &beta;-thalassemia trait globin synthetic ratios, and has be...

Full description

Bibliographic Details
Main Author: S.P. Perrine
Format: Article
Language:English
Published: PAGEPress Publications 2011-12-01
Series:Thalassemia Reports
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/thal/article/view/297